Customer Logins

Obtain the data you need to make the most informed decisions by accessing our extensive portfolio of information, analytics, and expertise. Sign in to the product or service center of your choice.

Customer Logins

Episode 46: The impact of COVID-19 on the healthcare industry and policy decisions

12 June 2020 17:31 Gustav Ando Milena Izmirlieva

As countries and organizations start to reopen, the question top-of-mind for many is when will a vaccine, or other treatment, be available? Many hold out hope that a vaccine will be the magic bullet — it’s not that simple. Our life science’s experts Gustav Ando and Milena Izmirlieva spend todays’ episode discussing the challenges and opportunities for developing a vaccine as well as the alternative therapies that are being tested in tandem to alleviate many of the symptoms of COVID-19. How has the industry risen to the challenge and what does this mean for future R&D?

SUBSCRIBE:  Apple   |   Stitcher   |   Spotify   |   RSS   |   Google Play

Speaker: Gustav Ando, Vice President, Industry Services & Life Sciences, IHS Markit and

Milena Izmirlieva, Director, Life Sciences Research, IHS Markit

Filter Sort